Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 48
Filter
1.
Community Ment Health J ; 51(2): 185-9, 2015 Feb.
Article in English | MEDLINE | ID: mdl-24817259

ABSTRACT

When psychiatric hospitalization is over-used, it represents a financial drain and failure of care. We evaluated implementation and cessation of transporting people medically certified for psychiatric hospitalization to a central psychiatric emergency service for management and re-evaluation of hospitalization need. After implementation, the hospitalization rate declined 89% for 346 transported patients; only four of the nonhospitalized patients presented in crisis again in the next 30 days. Following cessation, the hospitalization rate jumped 59% compared to the preceding year. Costs declined 78.7% per diverted patient. The findings indicate that it is possible to reduce hospitalization and costs, and maintain quality care.


Subject(s)
Crisis Intervention/methods , Emergency Services, Psychiatric/methods , Hospitalization/statistics & numerical data , Mental Disorders/therapy , Adult , Community Mental Health Services/economics , Cost-Benefit Analysis , Crisis Intervention/statistics & numerical data , Emergency Services, Psychiatric/economics , Female , Hospitalization/economics , Hospitals, Psychiatric , Humans , Inpatients , Male , Mental Disorders/epidemiology , Michigan/epidemiology , Middle Aged , Outcome and Process Assessment, Health Care , Young Adult
2.
Article in English | MEDLINE | ID: mdl-24121061

ABSTRACT

Adolescents and young adults disproportionately abuse 3,4-methylenedioxymethamphetamine (MDMA; 'Ecstasy'); however, since most MDMA research has concentrated on adults, the effects of MDMA on the developing brain remain obscure. Therefore, we evaluated place conditioning to MDMA (or saline) during late adolescence and assessed anxiety-like behavior and monoamine levels during abstinence. Rats were conditioned to associate 5 or 10mg/kg MDMA or saline with contextual cues over 4 twice-daily sessions. Five days after conditioning, anxiety-like behavior was examined with the open field test and brain tissue was collected to assess serotonin (5-hydroxytryptamine, 5-HT) and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) in the dorsal raphe, amygdala, and hippocampus by high-pressure liquid chromatography (HPLC). In a separate group of rats, anxiety-like and avoidant behaviors were measured using the light-dark box test under similar experimental conditions. MDMA conditioning caused a place aversion at 10, but not at 5, mg/kg, as well as increased anxiety-like behavior in the open field and avoidant behavior in light-dark box test at the same dose. Additionally, 10mg/kg MDMA decreased 5-HT in the dorsal raphe, increased 5-HT and 5-HIAA in the amygdala, and did not alter levels in the hippocampus. Overall, we show that repeated high (10mg/kg), but not low (5mg/kg), dose MDMA during late adolescence in rats increases anxiety-like and avoidant behaviors, accompanied by region-specific alterations in 5-HT levels during abstinence. These results suggest that MDMA causes a region-specific dysregulation of the serotonin system during adolescence that may contribute to maladaptive behavior.


Subject(s)
Behavior, Animal/drug effects , Brain/drug effects , Brain/metabolism , Hallucinogens/administration & dosage , N-Methyl-3,4-methylenedioxyamphetamine/administration & dosage , Adaptation, Ocular/drug effects , Analysis of Variance , Animals , Animals, Newborn , Chromatography, High Pressure Liquid , Conditioning, Operant/drug effects , Dose-Response Relationship, Drug , Drug Administration Schedule , Exploratory Behavior/drug effects , Hydroxyindoleacetic Acid/metabolism , Male , Rats , Rats, Sprague-Dawley , Serotonin/metabolism , Time Factors
3.
Fertil Steril ; 100(4): 1068-76, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23830149

ABSTRACT

OBJECTIVE: To examine and compare brain activation patterns of premenopausal women with normal sexual function and those with hypoactive sexual desire disorder (HSDD) during viewing of validated sexually explicit film clips. DESIGN: Cross-sectional pilot study. SETTING: University-based clinical research center. PATIENT(S): Premenopausal women. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Areas of brain activation during viewing of sexually explicit film clips. RESULT(S): Women with normal sexual function showed significantly greater activation of the right thalamus, left insula, left precentral gyrus, and left parahippocampal gyrus in comparison with women with HSDD, who exhibited greater activation of the right medial frontal gyrus and left precuneus regions. CONCLUSION(S): Women with HSDD may have alterations in activation of limbic and cortical structures responsible for acquiring, encoding, and retrieving memory, the processing and memory of emotional reactions, and areas responsible for heightened attention to one's own physical state.


Subject(s)
Brain Mapping , Brain Waves , Brain/physiopathology , Sexual Behavior , Sexual Dysfunctions, Psychological/physiopathology , Adult , Brain Mapping/methods , Case-Control Studies , Cross-Sectional Studies , Emotions , Female , Humans , Linear Models , Magnetic Resonance Imaging , Male , Photic Stimulation , Pilot Projects , Premenopause , Sex Factors , Sexual Dysfunctions, Psychological/diagnosis , Sexual Dysfunctions, Psychological/psychology , Video Recording , Visual Perception
4.
J Psychiatr Res ; 47(10): 1492-8, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23835042

ABSTRACT

The presence and magnitude of information processing deviations associated with Post-Traumatic Stress Disorder (PTSD) are far from being well-characterized. In this study we assessed the auditory and visually evoked cerebral responses in a group of Iraqi refugees who were exposed to torture and developed PTSD (N = 20), Iraqi refugees who had been exposed to similar trauma but did not develop PTSD (N = 20), and non-traumatized controls matched for age, gender, and ethnicity (N = 20). We utilized two paired-stimulus paradigms in auditory and visual sensory modalities, respectively. We found significantly smaller amplitudes of both the auditory P50 and the visual N75 responses in PTSD patients compared to controls, reflecting decreased response to simple sensory input during a relatively early phase of information processing (interval 50-75 ms post stimulus). In addition, deficient suppression of the P50/N75 response to repeating stimuli at this early stage in both modalities is indicative of difficulty in filtering out irrelevant sensory input. Among associations between electrophysiological and clinical measures, a significant positive correlation was found between dissociation score and P50 S1 amplitudes (p = 0.024), as well as stronger auditory P50 gating correlated with higher quality-of-life index scores (p = 0.013). In addition, smaller amplitudes of N150 visual evoked response to S1 showed a significant association with higher avoidance scores (p = 0.015). The results of this study highlight the importance of early automatic auditory and visual evoked responses in probing the information processing and neural mechanisms underlying symptomatology in PTSD.


Subject(s)
Evoked Potentials/physiology , Sensory Gating/physiology , Stress Disorders, Post-Traumatic/physiopathology , Stress Disorders, Post-Traumatic/psychology , Torture/psychology , Acoustic Stimulation , Adult , Electroencephalography , Female , Humans , Male , Middle Aged , Photic Stimulation
5.
Menopause ; 18(8): 893-6, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21540755

ABSTRACT

OBJECTIVE: The aim of this study was to determine the effects of 10 and 20 mg/day of escitalopram on objectively recorded hot flashes and on the rectal temperature threshold for sweating. METHODS: Two studies were performed: 16 women received 10 mg/day and 26 women received 20 mg/day escitalopram for 8 weeks. They were randomly assigned in equal numbers to receive active drug or placebo in a double-blind fashion. Hot flash frequency was measured with an ambulatory recorder during the first 3 weeks and during the 8th week of the study. Rectal temperature threshold for sweating was measured during the 1st and 8th weeks of the study using published methods. RESULTS: In the first study, there were no significant effects whatsoever for any measure. In the second study, the escitalopram group showed an average decline in hot flash frequency of 14.4%, whereas the placebo group showed an average increase of 6.7% (P < 0.05). However, there were no significant effects across time for either group. There were no significant effects whatsoever for rectal temperature sweating thresholds. CONCLUSIONS: Escitalopram at 10 or 20 mg/day is not effective in the treatment of menopausal hot flashes.


Subject(s)
Citalopram/administration & dosage , Hot Flashes/drug therapy , Selective Serotonin Reuptake Inhibitors/administration & dosage , Severity of Illness Index , Women's Health , Dose-Response Relationship, Drug , Double-Blind Method , Female , Hot Flashes/prevention & control , Humans , Menopause/drug effects , Quality of Life/psychology , Treatment Outcome
6.
J Sex Marital Ther ; 37(1): 56-69, 2011.
Article in English | MEDLINE | ID: mdl-21218331

ABSTRACT

In natural cycles of attempted conception, stress has been shown to predict lower conception rates. The objective of this article is to determine whether stress affects the outcome of assisted reproductive technology (ART) as well. In addition, this article analyzes the effect that psychosocial interventions targeting the reduction of stress have on ART outcomes. This review examined available PubMed articles published in the past 15 years, and 28 articles were included. Looking specifically at numbers of women studied, stress appears to negatively affect ART outcome; interventions targeting stress reduction appear beneficial. Because stress appears to negatively affect ART outcome, and psychosocial interventions do not have detrimental effects, screening for stress should occur and some type of intervention considered during the ART process.


Subject(s)
Infertility/psychology , Marriage/psychology , Reproductive Techniques, Assisted/psychology , Stress, Psychological/epidemiology , Adaptation, Psychological , Female , Humans , Infertility/epidemiology , Marriage/statistics & numerical data , Pregnancy , Pregnancy Outcome/epidemiology , Reproductive Techniques, Assisted/statistics & numerical data , Risk Factors , Stress, Psychological/prevention & control , Women's Health
7.
Ann Noninvasive Electrocardiol ; 15(2): 165-74, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20522058

ABSTRACT

BACKGROUND: Age has been identified as an independent risk factor for cardiovascular diseases. In addition, autonomic imbalance toward sympathetic preponderance has been shown to facilitate the occurrence of heart disease. Here, we aimed to assess autonomic modulation of cardiovascular parameters during normal ageing applying well-established linear and novel nonlinear parameters. METHODS: Linear and nonlinear measures of heart rate variability and complexity as well as measures of QT interval variability and baroreflex sensitivity were obtained from a total of 131 healthy, medication-free participants from a continuous age range between 20 and 90 years, who were allocated to three different age groups. RESULTS: Heart rate variability and complexity significantly decreased with age, while regularity of heart rate time series increased. In addition, QT interval variability linearly increased with age, while baroreflex sensitivity showed a pronounced decrease. Overall, concerning effects of ageing, linear and nonlinear parameters showed equal differentiation between groups. CONCLUSION: These data indicate a shift of autonomic balance toward sympathetic predominance in higher age groups, limiting the reactiveness of the cardiovascular system to adjust to different demands and increasing the risk for developing tachyarrhythmias.


Subject(s)
Baroreflex , Electrocardiography/methods , Heart Rate , Adult , Age Factors , Aged , Aged, 80 and over , Alcohol Drinking , Analysis of Variance , Blood Pressure , Female , Humans , Life Style , Male , Middle Aged , Sex Factors , Smoking , Young Adult
8.
9.
Prog Neuropsychopharmacol Biol Psychiatry ; 34(2): 406-11, 2010 Mar 17.
Article in English | MEDLINE | ID: mdl-20083149

ABSTRACT

Previous studies have observed reduced vagal modulation in patients with acute schizophrenia and their first-degree relatives, thus suggesting a genetic predisposition. To investigate vagal modulation, we analyzed the coupling between heart rate and breathing as a putative measure of central autonomic function in 19 patients, 19 of their relatives and 19 matched control subjects. The interaction of heart rate and breathing was investigated in all groups applying the non-linear parameter cross-ApEn, indicating the asynchrony between both time series. In addition, measures of the time and frequency domain of heart rate variability (HRV) were obtained. The main finding of our study is a significantly increased cross-ApEn value, indicating reduced central vagal modulation both in relatives and patients suffering from schizophrenia. Non-linear measures of HRV proved to more sensitively differentiate relatives from control subjects. Furthermore, we observed a correlation between psychopathology and breathing, indicating that positive symptoms are associated with a higher degree of regularity in the breathing pattern. Our results suggest that autonomic dysfunction previously described for patients suffering from schizophrenia is also present in first-degree relatives. This might relate to changes of brainstem activity in patients and relatives, and a common genetic background in patients and their family members can be assumed.


Subject(s)
Family , Heart Rate/physiology , Respiratory Mechanics/physiology , Schizophrenia , Vagus Nerve/physiopathology , Adolescent , Adult , Analysis of Variance , Electrocardiography/methods , Entropy , Female , Follow-Up Studies , Humans , Male , Middle Aged , Nonlinear Dynamics , Personality/genetics , Schizophrenia/genetics , Schizophrenia/pathology , Schizophrenia/physiopathology , Statistics, Nonparametric , Young Adult
10.
Article in English | MEDLINE | ID: mdl-19819283

ABSTRACT

BACKGROUND: Somatic symptoms of the gastrointestinal tract occur frequently in major depressive disorder (MDD) and might be associated with the known autonomic imbalance in the disease. Hence, we have investigated gastric electrical activity in patients suffering from major depression before and after treatment by means of electrogastrography (EGG) to investigate a putative association with either the disease state and its symptoms or its relation to the treatment. METHODS: EGG readings before and after ingestion of a test meal of 27 patients suffering from major depression were recorded before and after treatment with antidepressants and compared with age-matched controls. Abdominal symptoms were rated by a specific Autonomic Nervous Symptom-score. RESULTS: We found a significantly increased amount of tachygastria before and after medication, indicating increased sympathetic modulation. A significant difference was observed for the instability coefficients before and after medication, indicating gastric dysmotility in our patients prior to treatment. The elevated approximate entropy measure points to increased complexity and dysregulation. Furthermore, we have observed a correlation between subjective sensation of sweating and dry mouth with the sympathetic parameter tachygastria. DISCUSSION: Our results suggest that major depression is associated with gastric dysrhythmia possibly caused by increased sympathetic modulation. Linear and non-linear EGG measures emphasize a possible role of the autonomic nervous system in the development of gastric symptoms. The treatment with antidepressants seems to increase the activity of the sympathetic nervous system, without aggravating gastric symptoms. The association of increased sympathetic modulation with somatic symptoms was indicated by correlation analysis with these symptoms.


Subject(s)
Antidepressive Agents/adverse effects , Depressive Disorder, Major/complications , Gastrointestinal Motility/physiology , Stomach Diseases/etiology , Adult , Analysis of Variance , Case-Control Studies , Depressive Disorder, Major/drug therapy , Electrodiagnosis/methods , Entropy , Female , Gastrointestinal Motility/drug effects , Humans , Male , Middle Aged , Psychiatric Status Rating Scales , Statistics as Topic , Surveys and Questionnaires , Young Adult
12.
Sleep ; 32(11): 1513-9, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19928391

ABSTRACT

STUDY OBJECTIVE: 3,4-Methylenedioxymethamphetamine (MDMA) affects monoamine neurotransmitters that play a critical role in sleep and daytime alertness. However, the acute effects of MDMA on sleep and daytime sleepiness have not been studied under placebo-controlled conditions. This study was designed to establish the effects of acute MDMA or placebo administration and sleep restriction on sleep and daytime sleepiness. DESIGN: Participants with a history of MDMA use were studied on 3 sessions of 3 nights (baseline, treatment, and recovery) and 2 days (following night 2 and 3) per session. On treatment nights (night 2), participants received placebo or 2 mg/kg of MDMA or underwent a restricted bed schedule with placebo. Sleep restriction was a positive control to compare sleep loss and consequent sleepiness associated with MDMA use. The scheduled sleep period was 8 hours long on nonrestricted nights, and standard sleep recordings and daytime sleepiness tests were conducted. Age-matched controls received 1 night and day of standard sleep and daytime sleepiness testing. SETTING: Sleep laboratory. PARTICIPANTS: Seven recreational MDMA-users and 13 matched control subjects. MEASUREMENTS AND RESULTS: Acute MDMA shortened sleep primarily by increasing sleep latency, and it reduced stage 3/4 sleep and suppressed rapid eye movement (REM) sleep. The MDMA-reduced sleep time was not associated with increased daytime sleepiness the following day, as was seen in the sleep-restriction condition. Compared with control subjects, the MDMA users on the first night in the laboratory had shorter total sleep times and less stage 3/4 sleep. Average daily sleep latency on daytime sleepiness tests the day after nighttime placebo administration was increased in MDMA users compared with the control subjects, and MDMA users had an elevated number of sleep-onset REM periods on these tests, compared with control subjects. CONCLUSIONS: Acute MDMA administration disrupts sleep and REM sleep, specifically, without producing daytime sleepiness such as sleep restriction does. Compared with control subjects, recreational MDMA users showed evidence of hyperarousal and impaired REM function. The mechanism behind these effects is likely due to the deleterious effects of MDMA on catecholamines.


Subject(s)
Adrenergic Uptake Inhibitors/pharmacology , Amphetamine-Related Disorders/psychology , N-Methyl-3,4-methylenedioxyamphetamine/pharmacology , Sleep/drug effects , Wakefulness/drug effects , Adrenergic Uptake Inhibitors/administration & dosage , Adult , Amphetamine-Related Disorders/complications , Amphetamine-Related Disorders/physiopathology , Cohort Studies , Double-Blind Method , Female , Humans , Male , N-Methyl-3,4-methylenedioxyamphetamine/administration & dosage , Polysomnography , Recovery of Function , Time Factors , Young Adult
13.
Prog Neuropsychopharmacol Biol Psychiatry ; 33(7): 1236-40, 2009 Oct 01.
Article in English | MEDLINE | ID: mdl-19602429

ABSTRACT

Cardiac autonomic dysfunction has been reported in patients suffering from schizophrenia. The aim of the present study was to evaluate gastric electrical activity in unmedicated patients suffering from acute schizophrenia in relation to their symptoms. Electrogastrography was performed before and after test meal ingestion in 26 patients suffering from schizophrenia and 26 matched controls. The non-linear measure approximate entropy (ApEn) was calculated for the first time from the obtained signal in addition to standardized measures. Results were correlated with the scales for the assessment of positive symptoms and negative symptoms. In addition, autonomic and abdominal symptoms were assessed by the autonomic symptom score. We found a significantly increased amount of tachygastria and arrhythmia within the signal of the activity of the gastric pacemaker before and after test meal digestion in patients compared to controls, indicating increased sympathetic modulation within the enteric nervous system. A significant difference was observed for slow wave, which represents the dominant frequency of gastric pacemaker activity, indicating gastric dysmotility in our patients. The elevated ApEn measure points to increased complexity and dysregulation. In addition, we have observed a correlation between delusions and tachygastria. Sympathetic function seems to be altered in the enteric nervous system of patients suffering from schizophrenia. Future studies need to explore the influence of the disease on different branches of the autonomic nervous system and clinical consequences of enteric dysfunction. Our findings point to a possible systemic autonomic imbalance that needs to be studied in respect to the neurobiology of schizophrenia.


Subject(s)
Linear Models , Nonlinear Dynamics , Schizophrenia/complications , Stomach Diseases/diagnosis , Stomach Diseases/etiology , Adult , Analysis of Variance , Arrhythmias, Cardiac/etiology , Case-Control Studies , Electrocardiography , Electroencephalography/methods , Enteric Nervous System/physiopathology , Entropy , Female , Heart/physiopathology , Humans , Male , Middle Aged , Psychiatric Status Rating Scales , Vagus Nerve/physiopathology , Young Adult
15.
NMR Biomed ; 22(4): 419-25, 2009 May.
Article in English | MEDLINE | ID: mdl-18985626

ABSTRACT

Despite the potential for deleterious (even fatal) effects on cardiac physiology, 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) abuse abounds driven mainly by its euphoric effects. Acute exposure to MDMA has profound cardiovascular effects on blood pressure and heart rate in humans and animals. To determine the effects of MDMA on cardiac metabolites in rats, MDMA (0, 5, or 10 mg/kg) was injected every 2 h for a total of four injections; animals were sacrificed 2 h after the last injection (8 h drug exposure), and their hearts removed and tissue samples from left ventricular wall dissected. High resolution magic angle spinning proton magnetic resonance spectroscopy ((1)H-MRS) at 11.7 T, a specialized version of MRS aptly suited for analysis of semi-solid materials such as intact tissue samples, was used to measure the cardiac metabolomic profile, including alanine, lactate, succinate, creatine, and carnitine, in heart tissue from rats treated with MDMA. MDMA effects on MR-visible choline, glutamate, glutamine, and taurine were also determined. Body temperature was measured following each MDMA administration and serotonin and norepinephrine (NE) levels were measured by high pressure liquid chromatography (HPLC) in heart tissue from treated animals. MDMA significantly and dose-dependently increased body temperature, a hallmark of amphetamines. Serotonin, but not NE, levels were significantly and dose-dependently decreased by MDMA in the heart wall. MDMA significantly altered the MR-visible profile with an increase in carnitine and no change in other key compounds involved in cardiomyocyte energy metabolomics. Finally, choline levels were significantly decreased by MDMA in heart. The results are consistent with the notion that MDMA has significant effects on cardiovascular serotonergic tone and disrupts the metabolic homeostasis of energy regulation in cardiac tissue, potentially increasing utilization of fatty acid metabolism. The contributions of serotonergic signaling on MDMA-induced changes in cardiac metabolism remain to be determined.


Subject(s)
Heart/drug effects , Metabolome/drug effects , N-Methyl-3,4-methylenedioxyamphetamine/pharmacology , Animals , Body Temperature/drug effects , Choline/metabolism , Magnetic Resonance Spectroscopy , Male , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/metabolism , Norepinephrine/metabolism , Organ Specificity/drug effects , Protons , Rats , Rats, Sprague-Dawley , Serotonin/metabolism
16.
J Clin Psychopharmacol ; 28(6): 694-8, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19011440

ABSTRACT

Previous studies have shown that untreated patients with acute schizophrenia present with reduced heart rate variability and complexity as well as increased QT variability. This autonomic dysregulation might contribute to increased cardiac morbidity and mortality in these patients. However, the additional effects of newer antipsychotics on autonomic dysfunction have not been investigated, applying these new cardiac parameters to gain information about the regulation at sinus node level as well as the susceptibility to arrhythmias. We have investigated 15 patients with acute schizophrenia before and after established olanzapine treatment and compared them with matched controls. New nonlinear parameters (approximate entropy, compression entropy, fractal dimension) of heart rate variability and also the QT-variability index were calculated. In accordance with previous results, we have observed reduced complexity of heart rate regulation in untreated patients. Furthermore, the QT-variability index was significantly increased in unmedicated patients, indicating increased repolarization lability. Reduction of the heart rate regulation complexity after olanzapine treatment was seen, as measured by compression entropy of heart rate. No change in QT variability was observed after treatment. This study shows that unmedicated patients with acute schizophrenia experience autonomic dysfunction. Olanzapine treatment seems to have very little additional impact in regard to the QT variability. However, the decrease in heart rate complexity after olanzapine treatment suggests decreased cardiac vagal function, which may increase the risk for cardiac mortality. Further studies are warranted to gain more insight into cardiac regulation in schizophrenia and the effect of novel antipsychotics.


Subject(s)
Antipsychotic Agents/therapeutic use , Autonomic Nervous System/drug effects , Benzodiazepines/therapeutic use , Heart Rate/drug effects , Heart/innervation , Schizophrenia/drug therapy , Acute Disease , Adult , Antipsychotic Agents/adverse effects , Autonomic Nervous System/physiopathology , Benzodiazepines/adverse effects , Case-Control Studies , Female , Humans , Male , Olanzapine , Psychiatric Status Rating Scales , Schizophrenia/physiopathology , Schizophrenic Psychology , Time Factors , Treatment Outcome , Young Adult
17.
Depress Anxiety ; 25(3): 241-7, 2008.
Article in English | MEDLINE | ID: mdl-17345601

ABSTRACT

Previous research has suggested that 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) users have elevated depressive symptomatology, although it is not clear whether this is due to MDMA or other drug use. This study aimed to investigate the contributions of MDMA and cannabis use to Major Depressive Disorder in MDMA users. A total of 226 MDMA users were studied. Participants (65% male) reported an average number of 35.8 uses of MDMA (SD = 45.6, range = 2-400). Participants were administered a Structured Clinical Interview for DSM-IV. Twenty-six individuals (11.5%) met lifetime criteria for Major Depressive Disorder. High rates of lifetime Cannabis Abuse (30.1%) and Cannabis Dependence (12.4%) were reported. No association was found between number of uses of MDMA and Major Depressive Disorder. Those with lifetime major depression were found, however, to have higher rates of lifetime cannabis use disorder (adjusted OR = 2.40). A logistic regression indicated that lifetime cannabis use disorder, but not MDMA use, was significantly associated with lifetime Major Depressive Disorder. Stratified analyses suggested that for males, neither drug use variable was associated with major depression. For females, a lifetime cannabis use disorder (adjusted OR = 4.99), but not MDMA use, was associated with lifetime Major Depressive Disorder. Results of this study suggest that although MDMA use was not found to be significantly associated with major depression for either gender, a lifetime cannabis use disorder was significantly associated with lifetime major depression for female, but not male, users of MDMA.


Subject(s)
Depressive Disorder, Major/epidemiology , Marijuana Abuse/epidemiology , N-Methyl-3,4-methylenedioxyamphetamine/adverse effects , Substance-Related Disorders/epidemiology , Adult , Comorbidity , Depressive Disorder, Major/diagnosis , Depressive Disorder, Major/psychology , Diagnostic and Statistical Manual of Mental Disorders , Educational Status , Female , Humans , Male , Marijuana Abuse/diagnosis , Marijuana Abuse/psychology , Psychiatric Status Rating Scales/statistics & numerical data , Regression Analysis , Sex Factors , Substance-Related Disorders/diagnosis , Substance-Related Disorders/psychology , Surveys and Questionnaires
18.
J Sex Med ; 5(1): 146-54, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17956555

ABSTRACT

INTRODUCTION: Erotic film clips are used in sex research, including studies of female sexual dysfunction and arousal. However, little is known about which clips optimize female sexual response. Furthermore, their use is not well standardized. AIMS: To identify the types of film clips that are most mentally appealing and physically arousing to women for use in future sexual function and dysfunction studies; to explore the relationship between mental appeal and reported physical arousal; to characterize the content of the films that were found to be the most and least appealing and arousing. METHODS: Twenty-one women viewed 90 segments of erotic film clips. They rated how (i) mentally appealing and (ii) how physically aroused they were by each clip. The data were analyzed by descriptive statistics. The means of the mental and self-reported physical responses were calculated to determine the most and least appealing/arousing film clips. Pearson correlations were calculated to assess the relationship between mental appeal and reported physical arousal. MAIN OUTCOME MEASURES: Self-reported mental and physical arousal. RESULTS: Of 90 film clips, 18 were identified as the most mentally appealing and physically arousing while nine were identified as the least mentally appealing and physically arousing. The level of mental appeal positively correlated with the level of perceived physical arousal in both categories (r = 0.61, P < 0.05 and r = 0.62, P < 0.05). The most appealing and physically arousing films tended to exhibit heterosexual behavior with vaginal intercourse. The least appealing and least physically arousing films tended to depict male homosexual behavior, fellatio, and anal intercourse. CONCLUSIONS: Erotic film clips reliably produced a state of self-reported arousal in women. The most appealing and arousing films tended to depict heterosexual vaginal intercourse. Film clips with these attributes should be used in future research of sexual function and response of women.


Subject(s)
Erotica , Libido , Motion Pictures , Research Design/standards , Visual Perception , Adult , Female , Humans , Mental Health , Middle Aged , Personal Satisfaction , Reproducibility of Results , Surveys and Questionnaires , Women's Health
20.
Psychosom Med ; 69(8): 717-22, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17942845

ABSTRACT

OBJECTIVE: To compare the left-right differences in pulse wave velocity (PWV) measures in normal controls and patients with anxiety disorders and cardiac disease. Pulses from the right and left sides of normal subjects are highly correlated at each segmental level. However, some evidence suggests that the right hemisphere has a greater effect on parasympathetic activity, as there may be a right hemisphere disadvantage in patients with low cardiac vagal function. Decreased vagal function is associated with vascular dysfunction and hypertension. METHODS: We compared normal controls (n = 22), patients with anxiety (n = 26), and patients with cardiovascular disease (n = 72) using the Vascular Profiler (VP-1000), which enables the measurement of ankle and brachial blood pressure (BP) in both arms (brachial), both legs (ankle) and carotid artery, and lead I electrocardiogram and phonocardiogram. Using these signals, PWV, and arterial stiffness index % were calculated for the comparison of these measures on the right and left sides of the body. RESULTS: Patients with anxiety and cardiovascular disease had significantly higher left-right differences in heart-ankle pulse wave velocity, brachial-ankle pulse wave velocity, and arterial stiffness index percentage compared with that of normal controls. Our data also showed significant differences between left-right vascular indices in patients with anxiety and cardiovascular disease (p < .00001); there was no such significant difference in normal controls. CONCLUSIONS: These results may implicate an exaggerated vagal withdrawal in the left extremities resulting in higher PWV in patients with anxiety and cardiovascular illness.


Subject(s)
Anxiety Disorders/physiopathology , Blood Pressure/physiology , Cardiovascular Diseases/physiopathology , Adult , Ankle/blood supply , Brachial Artery/physiology , Case-Control Studies , Elasticity , Female , Functional Laterality , Humans , Male , Middle Aged , Vagus Nerve/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...